88
Participants
Start Date
January 1, 2017
Primary Completion Date
January 1, 2021
Study Completion Date
January 1, 2021
bupivacaine and methylprednisolone
5 mL of 0.25% bupivacaine containing 20 mg methylprednisolone was administered to the subacromial area
bupivacaine and methylprednisolone
5 mL of 0.25% bupivacaine containing 20 mg methylprednisolone was administered to the subacromial area for the subacromial+acromioclavicular joint injection. In addition, 2 mL of 20 mg methylprednisolone and the same concentration of local anaesthetic were injected into the acromioclavicular joint
bupivacaine and methylprednisolone
suprascapular nerve block was administered with a mixture of 10 mL of 0.25% bupivacaine and 40 mg methylprednisolone
Bursa Yuksek Ihtisas Training and Research Hospital
OTHER_GOV